+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Synthetic Biology - Global Strategic Business Report

  • PDF Icon

    Report

  • 442 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1382378

Global Synthetic Biology Market to Reach $77.5 Billion by 2030

The global market for Synthetic Biology estimated at US$10.8 Billion in the year 2022, is projected to reach a revised size of US$77.5 Billion by 2030, growing at a CAGR of 27.9% over the analysis period 2022-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is projected to record 29.1% CAGR and reach US$35.7 Billion by the end of the analysis period. Growth in the Enzymes segment is estimated at 26.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 32.5% CAGR

The Synthetic Biology market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 32.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.2% and 27.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 29.2% CAGR.

Select Competitors (Total 141 Featured)

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Agrivida, Inc.
  • ATG Biosynthetics GmbH
  • Algentech SAS
  • Arzeda
  • AdvanceSyn
  • Asimov, Inc.
  • ArsenalBio
  • Abiochem Biotechnology
  • Accelerbiotics
  • Antheia
  • Ardra Bio
  • Baccuico
  • Absci Corp.

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Synthetic Biology Market

What is the estimated value of the Synthetic Biology Market?

The Synthetic Biology Market was estimated to be valued at $10.8 Billion in 2022.

What is the growth rate of the Synthetic Biology Market?

The growth rate of the Synthetic Biology Market is 27.9%, with an estimated value of $77.5 Billion by 2030.

What is the forecasted size of the Synthetic Biology Market?

The Synthetic Biology Market is estimated to be worth $77.5 Billion by 2030.

Who are the key companies in the Synthetic Biology Market?

Key companies in the Synthetic Biology Market include Agilent Technologies, Inc., Amyris, Inc., Agrivida, Inc., ATG Biosynthetics GmbH, Algentech SAS, Arzeda, AdvanceSyn, Asimov, Inc., ArsenalBio and Abiochem Biotechnology.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19 Pandemic Poised to Drive Demand for Synthetic Biology
  • Synthetic Biologists Create Slow-Growing Version of COVID-19 as Vaccine Candidate
  • Role of Synthetic Biology in Combating COVID-19
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Synthetic Biology - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Synthetic Biology - A New Interdisciplinary Field
  • Growing Importance of Synthetic Biology
  • Applications of Synthetic Biology
  • Synthetic Biology Tools
  • Technologies Involved
  • Market Outlook
  • Regional Landscape
  • Major Challenges and Concerns
  • Teaming R&D Funding & Potential to Alter Molecular Landscape Enable Global Synthetic Biology Market to Remain in High Spirits
  • Synthetic Biology to Radically Change the World for Good with Endless Applications
  • Competitive Landscape
  • Major Players by Industry Verticals
  • Select Market Participants
  • Synthetic Biology Startups Get Aggressive on Bioengineered Product Commercialization
  • Compelling Breakthroughs Drive Funding
  • Top Funded Synthetic Biology Startups in Q2 2020
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Synthetic Biology Market Witnesses Significant Rise in Investments
  • Importance of Synthetic Biology for Investments
  • Efforts from Leading Players Bodes Well for Market Growth
  • Patent Landscape Gets Richer
  • Synthetic Biology Patent Landscape by Assignee Countries (in %) : 2003-2020
  • Top 15 Patent Assignees in Synthetic Biology Domain: 2003-2018
  • Select Patent Assignees for Synthetic Biology in the US: 2019
  • Robotics and Workflow Automation Support Market Expansion
  • Advancements in Instrumentation Augurs Well
  • Improvements in Computer-Aided Biology
  • Fusion of AI and Synthetic Biology Expands Opportunities
  • Synthetic Biology Brings a Paradigm Shift in the Field of Biological Research
  • DNA Sequencing Plays an Important Role
  • Plummeting Cost of DNA Sequencing Bolsters Market Growth
  • Cost per Genome Sequencing: 2001-2020
  • Food Scarcity to Fuel Synthetic Biology Application in Agriculture
  • Select Companies Engaged in Making Food Using Synthetic Biology
  • Synthetic Biology Aids in Development of Exotic and Artificially Grown Meats and Proteins to Meet Future Food Demand
  • Growing Demand for GM Crops Opens Up Growth Avenues
  • Synthetic Biology-based Ingredients Gain Traction
  • Role of Synthetic Biology in Producing Plants with Desirable Characteristics
  • Synthetic Biology Gains Prominence in Biomedical Applications
  • Synthetic Genes Open up a New World of Drug Development
  • Synthetic Biology to Transform Healthcare with Captivating Advances in Biomedicine
  • Synthetic Biology Enables Creation of Advanced Biosensing Systems
  • Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
  • Global Biofuels Market in US$ Billion: 2019 and 2024
  • Synthetic Biology Gains Importance as Focus on Carbon Recycling Increases
  • Synthetic Biology Disrupts the Cosmetics Sector
  • Capability of Synthetic Biology in Environmental Applications
  • Synthetic Biology Creates Buzz as Key Enabler of Exciting & Dynamic Applications for Diverse Domains
  • Synthetic Biology for Advanced, Multifunctional Materials
  • Genetically Engineered Fabrics and Sustainable Dyes Using Synthetic Biology to Transform Textile Industry
  • Select Synthetic Biology Offerings in Textile Industry
  • Personalized Medicine to Display Notable Leap Forward with Synthetic Biology
  • 3D Bio-Printing
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Synthetic Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 3: World 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Oligonucleotides & Synthetic DNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Oligonucleotides & Synthetic DNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 6: World 15-Year Perspective for Oligonucleotides & Synthetic DNA by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Cloning Technology Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Cloning Technology Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 12: World 15-Year Perspective for Cloning Technology Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Synthetic Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Synthetic Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 15: World 15-Year Perspective for Synthetic Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 18: World 15-Year Perspective for Xeno-Nucleic Acids (XNA) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Chassis Organism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Chassis Organism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 21: World 15-Year Perspective for Chassis Organism by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Nucleotide Synthesis & Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Nucleotide Synthesis & Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 24: World 15-Year Perspective for Nucleotide Synthesis & Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 27: World 15-Year Perspective for Genome Engineering by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 30: World 15-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 33: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Pharmaceuticals & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Pharmaceuticals & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 36: World 15-Year Perspective for Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 37: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 38: World Historic Review for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 39: World 15-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 40: World Recent Past, Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 41: World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 42: World 15-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 43: World Recent Past, Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 44: World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 45: World 15-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 46: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 47: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
  • TABLE 48: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2023 & 2030
  • TABLE 49: World Synthetic Biology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • CANADA
  • JAPAN
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • CHINA
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • EUROPE
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • FRANCE
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • GERMANY
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • ITALY
  • UNITED KINGDOM
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • REST OF WORLD
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Agrivida, Inc.
  • ATG Biosynthetics GmbH
  • Algentech SAS
  • Arzeda
  • AdvanceSyn
  • Asimov, Inc.
  • ArsenalBio
  • Abiochem Biotechnology
  • Accelerbiotics
  • Antheia
  • Ardra Bio
  • Baccuico
  • Absci Corp.